The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 25, 2023

Filed:

Nov. 11, 2019
Applicants:

Ares Trading S.a., Aubonne, CH;

Nicolas Chomont, Montreal, CA;

Jean-pierre Routy, Westmount, CA;

Inventors:

Alena Zalutskaya, Jamaica Plain, MA (US);

John Gourley, Plainville, MA (US);

Nicolas Chomont, Montreal, CA;

Jean-Pierre Routy, Westmount, CA;

Steven Deeks, San Francisco, CA (US);

Assignee:

ARES TRADING S.A., Aubonne, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/27 (2006.01); A61P 31/18 (2006.01); A61K 31/52 (2006.01); A61K 31/708 (2006.01); A61K 31/7068 (2006.01); A61K 31/341 (2006.01); A61K 31/675 (2006.01); A61K 31/496 (2006.01); A61K 31/536 (2006.01); A61K 31/505 (2006.01); A61K 31/551 (2006.01); A61K 31/7072 (2006.01);
U.S. Cl.
CPC ...
A61K 38/27 (2013.01); A61K 31/341 (2013.01); A61K 31/496 (2013.01); A61K 31/505 (2013.01); A61K 31/52 (2013.01); A61K 31/536 (2013.01); A61K 31/551 (2013.01); A61K 31/675 (2013.01); A61K 31/708 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61P 31/18 (2018.01);
Abstract

The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.


Find Patent Forward Citations

Loading…